Stock 002550 CHANGZHOU QIANHONG BIOPHARMA CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Changzhou Qianhong Biopharma CO.,LTD

Equities

002550

CNE100001070

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
4.97 CNY +1.43% Intraday chart for Changzhou Qianhong Biopharma CO.,LTD +6.42% -15.48%
Apr. 25 Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 22 Tranche Update on Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback Plan announced on January 3, 2024. CI

Business Summary

Changzhou Qianhong Biopharma CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of freeze-drying powder, freeze-drying powder injections, small volume injections, tablets, hard capsules, granules and bulk drugs, among others. The Company mainly provides liquaemin sodium raw materials and preparations, applied to prevent and treat thromboembolism desease; kallidinogen preparations, applied in the treatment of micro-circulation disorder disease, asparaginase bulk drugs and preparations, applied in the treatment of acute lymphoblastic leukemia, as well as compound digestive enzyme capsules II. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 1,102

Sales per Business

CNY in Million2021Weight2022Weight Delta
Preparation Series
51.3 %
1,210 64.5 % 1,182 51.3 % -2.34%
Active Pharmaceutical Ingredient Series
48.5 %
663 35.4 % 1,117 48.5 % +68.37%
Other
0.2 %
2 0.1 % 5 0.2 % +183.37%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
56.8 %
1,269 67.7 % 1,308 56.8 % +3.08%
Foreign
43.2 %
606 32.3 % 995 43.2 % +64.29%

Managers

Managers TitleAgeSince
Ke Wang CEO
 Chief Executive Officer 41 14-09-09
Ai Qun Xiao DFI
 Director of Finance/CFO 52 17-04-20
Wen Qun Jiang CHM
 Chairman 56 08-01-27
Xiang Zhou BRD
 Director/Board Member 42 17-08-17
Yong Fan BRD
 Director/Board Member 56 08-01-27
Yi Yao IRC
 Investor Relations Contact 42 21-01-27
Tao Hai PRN
 Corporate Officer/Principal 55 14-09-09
Li Jun Wei PRN
 Corporate Officer/Principal 52 -

Members of the board

Members of the board TitleAgeSince
Yao Fang Wang CHM
 Chairman 71 08-01-27
Gang Zhao BRD
 Director/Board Member 59 08-01-27
Yong Fan BRD
 Director/Board Member 56 08-01-27
Jian Ping Jiang BRD
 Director/Board Member 60 14-09-09
Jun Liu BRD
 Director/Board Member 57 08-01-27
Ke Wang CEO
 Chief Executive Officer 41 14-09-09
Guang Hua Xu BRD
 Director/Board Member 61 21-01-27
Tao Hai PRN
 Corporate Officer/Principal 55 14-09-09
Lei Chen BRD
 Director/Board Member 39 17-09-21
Xiang Zhou BRD
 Director/Board Member 42 17-08-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,284,800,000 766,752,256 ( 59.68 %) 5,000,000 ( 0.3892 %) 59.68 %

Shareholders

NameEquities%Valuation
Yao Fang Wang
6.880 %
63,850,500 6.880 % 43 M ¥
Changzhou Qianhong Biopharma Co. Ltd. ESOP
3.232 %
30,000,000 3.232 % 20 M ¥
Ren Yi Zhao
3.125 %
29,000,000 3.125 % 20 M ¥
Guan Xin Zhou
2.747 %
25,500,000 2.747 % 17 M ¥
Techsharpe Quant (Beijing) Capital Management Co. Ltd.
2.090 %
19,400,000 2.090 % 13 M ¥
Gang Zhao
1.867 %
17,325,250 1.867 % 12 M ¥
Ke Wang
1.708 %
15,852,400 1.708 % 11 M ¥
Lun Qing Qun
1.636 %
15,180,000 1.636 % 10 M ¥
Jian Ping Jiang
1.147 %
10,641,750 1.147 % 7 M ¥
Fullgoal Fund Management Co., Ltd.
0.7754 %
7,196,872 0.7754 % 5 M ¥
NameEquities%Valuation
Yao Fang Wang
53.46 %
191,551,500 53.46 % 130 M ¥
Gang Zhao
14.51 %
51,975,750 14.51 % 35 M ¥
Ke Wang
13.27 %
47,557,200 13.27 % 32 M ¥
Jian Ping Jiang
8.911 %
31,925,250 8.911 % 22 M ¥
Jun Liu
5.036 %
18,044,733 5.036 % 12 M ¥

Company contact information

Changzhou Qianhong Biopharma Co., Ltd.

518, Yunhe Road Xinbei District

213125, Changzhou

+

http://www.qhsh.com.cn
address Changzhou Qianhong Biopharma CO.,LTD(002550)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.97 CNY
Average target price
6.12 CNY
Spread / Average Target
+23.14%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHANGZHOU QIANHONG BIOPHARMA CO.,LTD Stock Changzhou Qianhong Biopharma CO.,LTD
-15.48% 878M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.28% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.36% 233B
NOVARTIS AG Stock Novartis AG
+5.41% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-10.27% 193B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 143B
AMGEN INC. Stock Amgen Inc.
-6.47% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002550 Stock
  4. Company Changzhou Qianhong Biopharma CO.,LTD